Zero ad trackers.We never sell your data.

Mantle Cell Lymphoma Clinical Trials Near Me

As of November 2, 2026, 131 Mantle Cell Lymphoma clinical trials are recruiting or about to open (106 recruiting now, 25 opening soon). In the US, 68 of them have at least 1 open site, across 47 states. Enter your ZIP code below to see which are closest to you.

Also on Trial Friend:Mantle Cell Lymphoma pageMatch Me

Trial Friend never receives or stores your ZIP code. Your browser looks up its location with a free map service.
Distance
Status
Ages
Phase
+250 more

All 106 Mantle Cell Lymphoma trials and their US sites

Enter your ZIP code above to sort them by how far their nearest open site is from you.

  1. Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
    Most sites in Illinois, Michigan and Wisconsin
    RecruitingPhase 3Ages 60+Alliance for Clinical Trials in Oncology
    220US sites
    30 states
  2. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
    Most sites in California, New York and Maryland
    RecruitingMassive Bio
    67US sites
    40 states
  3. A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
    Most sites in Ohio, North Carolina and Virginia
    RecruitingPhase 3Ages 18+BeOne Medicines
    41US sites
    26 states
  4. A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
    Most sites in New York, California and Florida
    RecruitingPhase 1/2Ages 18+BeOne Medicines
    28US sites
    18 states
  5. DALY II USA/ MB-CART2019.1 for DLBCL
    Most sites in Texas, Arizona and California
    RecruitingPhase 2Ages 18+Miltenyi Biomedicine
    28US sites
    23 states
  6. A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
    Most sites in New York, Colorado and Massachusetts
    RecruitingPhase 1Ages 18+Eli Lilly and Company
    23US sites
    18 states
  7. Study of SGR-1505 in Mature B-Cell Neoplasms
    Most sites in New York, Ohio and Arizona
    RecruitingPhase 1Ages 18+Schrödinger
    16US sites
    13 states
  8. A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
    Most sites in California, Florida and Ohio
    RecruitingPhase 1Ages 18+Nurix Therapeutics
    15US sites
    12 states
  9. A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
    Most sites in North Carolina, New Jersey and Pennsylvania
    RecruitingPhase 1/2Ages 18+AstraZeneca
    13US sites
    9 states
  10. AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
    Most sites in Florida, Texas and California
    RecruitingPhase 1Ages 18+Carna Biosciences
    13US sites
    11 states
  11. Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
    Most sites in California, Colorado and Florida
    RecruitingPhase 1/2Ages 13-90Vironexis Biotherapeutics
    11US sites
    10 states
  12. Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
    Most sites in Georgia, Ohio and California
    RecruitingPhase 2Ages 18+National Cancer Institute (NCI)
    11US sites
    8 states
  13. A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
    Most sites in California, Colorado and Illinois
    RecruitingPhase 1Ages 18+Nurix Therapeutics
    7US sites
    7 states
  14. A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
    Most sites in Florida, Indiana and Kansas
    RecruitingPhase 1/2Ages 18+BeOne Medicines
    6US sites
    6 states
  15. BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
    Most sites in Massachusetts, Arizona and Minnesota
    RecruitingPhase 2Ages 18+Christine Ryan
    6US sites
    5 states
  16. This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
    Most sites in New York, California and Missouri
    RecruitingPhase 1Ages 18+LTZ Therapeutics
    6US sites
    5 states
  17. A Study of APG-3288 in Relapsed/Refractory Blood Cancers
    Most sites in California, Florida and Michigan
    RecruitingPhase 1Ages 18+Ascentage Pharma Group
    5US sites
    5 states
  18. SynKIR-310 for Relapsed/Refractory B-NHL
    Most sites in Colorado, Georgia and Kansas
    RecruitingPhase 1Ages 18+Verismo Therapeutics
    5US sites
    5 states
  19. A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
    Most sites in Kansas, Missouri and Texas
    RecruitingPhase 1/2Ages 18+CRISPR Therapeutics
    4US sites
    4 states
  20. Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
    Only in California
    RecruitingPhase 2Ages 18+University of California, San Francisco
    4US sites
Get an email when Mantle Cell Lymphoma trials change

New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.

You'll get, for Mantle Cell Lymphoma:
  • Trial Alerts, when a new trial opens or a trial changes
  • Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Turn either off anytime from the link in every email.
We never share your email. Unsubscribe anytime. Privacy policy · Check any health site

Who runs the Mantle Cell Lymphoma trials in the US, and what stage they are in

Of the 68 Mantle Cell Lymphoma trials with a US site, 2 are in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 56 of them. The remaining 10 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 19 of them, and universities, hospitals, foundations and government groups run 49. The sponsors with the most are City of Hope Medical Center (8), BeOne Medicines (3) and Mayo Clinic (3). The most recently listed one first appeared on ClinicalTrials.gov on November 2, 2026.

Mantle Cell Lymphoma trials in the US, state by state

Of the 68 Mantle Cell Lymphoma trials with a US site, 7 accept children under 18. Their open sites are in 40 states, most often Minnesota, Colorado and New York. A trial counts once in each state where it has an open site, and some trials accept both children and adults.

StateTrialsChildrenAdultsCities with the most
California28228Duarte (16), Los Angeles (5), San Francisco (4), plus 10 more
New York16316New York (13), Buffalo (5), Valhalla (2), plus 13 more
Texas16216Houston (14), Dallas (4), San Antonio (2), plus 2 more
Florida14214Jacksonville (6), Miami (6), Tampa (5), plus 5 more
Ohio14214Columbus (10), Cleveland (5), Cincinnati (3), plus 3 more
Massachusetts13113Boston (11), Worcester (2)
Wisconsin12112Milwaukee (11), Madison (2), Appleton (1), plus 13 more
Minnesota11411Rochester (8), Duluth (2), Minneapolis (2), plus 12 more
North Carolina11211Durham (7), Chapel Hill (4), Winston-Salem (3), plus 1 more
Tennessee11211Nashville (11), Chattanooga (1), Memphis (1)
Show the other 37 states
Washington11211Seattle (10), Vancouver (1)
Colorado939Denver (7), Aurora (3), Fort Collins (1), plus 1 more
Georgia919Atlanta (8), Augusta (3), Albany (1), plus 3 more
Illinois919Chicago (9), Bloomington (1), Canton (1), plus 21 more
Maryland919Baltimore (5), Bethesda (5), Silver Spring (1), plus 1 more
Michigan919Ann Arbor (7), Detroit (2), Grand Rapids (2), plus 19 more
Pennsylvania919Philadelphia (5), Pittsburgh (4), Hershey (1), plus 1 more
Missouri818St Louis (8), Kansas City (2), Cape Girardeau (1), plus 5 more
New Jersey818New Brunswick (4), Hackensack (2), Basking Ridge (1), plus 4 more
Oregon828Portland (8), Ontario (1)
Utah717Salt Lake City (7)
Arizona616Gilbert (2), Phoenix (2), Scottsdale (2), plus 1 more
Connecticut616New Haven (5), Hartford (2), Derby (1), plus 11 more
Kansas606Westwood (4), Kansas City (2), Fairway (1), plus 7 more
Virginia616Charlottesville (4), Richmond (3), Gainesville (1)
Iowa515Iowa City (4), Waukee (2), Ames (1), plus 6 more
Alabama414Birmingham (4), Mobile (1)
Indiana404Fort Wayne (3), Crown Point (1), Dyer (1), plus 4 more
Rhode Island414Providence (4), Westerly (1)
Delaware313Newark (3)
Louisiana313Baton Rouge (2), New Orleans (1)
Nebraska313Omaha (3), Bellevue (1), Grand Island (1), plus 1 more
Arkansas212Little Rock (2)
Idaho212Boise (2), Caldwell (1), Coeur d'Alene (1), plus 3 more
Kentucky202Lexington (1), Louisville (1)
Mississippi212Hattiesburg (2)
Montana212Billings (2), Anaconda (1), Bozeman (1), plus 3 more
North Dakota212Fargo (2), Bismarck (1)
Oklahoma212Tulsa (2), Lawton (1), Oklahoma City (1)
South Carolina212Greenville (2), Boiling Springs (1), Charleston (1), plus 3 more
Maine111Scarborough (1)
Nevada101Las Vegas (1)
New Hampshire101Lebanon (1)
New Mexico111Albuquerque (1)
South Dakota101Sioux Falls (1)
Vermont101Saint Johnsbury (1)
West Virginia111Morgantown (1)

US hospitals running the most Mantle Cell Lymphoma trials

Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Mantle Cell Lymphoma.

  1. City of Hope Medical CenterDuarte, California7 trials
  2. City of HopeDuarte, California6 trials
  3. Colorado Blood Cancer InstituteDenver, Colorado4 trials
  4. Dana Farber Cancer InstituteBoston, Massachusetts4 trials
  5. Emory University Hospital/Winship Cancer InstituteAtlanta, Georgia4 trials
  6. MD Anderson Cancer CenterHouston, Texas4 trials
  7. Washington University School of MedicineSt Louis, Missouri4 trials
  8. Beth Israel Deaconess Medical CenterBoston, Massachusetts3 trials
  9. Dana-Farber Cancer InstituteBoston, Massachusetts3 trials
  10. Duke UniversityDurham, North Carolina3 trials

Help getting to a Mantle Cell Lymphoma trial far from home

Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.

These nonprofits also help patients reach care, and each one sets its own rules.

Mercy Medical Angels
Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
Air Charity Network
Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
Corporate Angel Network
Puts cancer patients in empty seats on business jets for treatment, second opinions and clinical trials. Open to anyone with cancer who can walk and travel without medical help, and it does not check income.
American Cancer Society Hope Lodge
Offers a free place to stay at 31 Hope Lodge locations for people getting cancer treatment far from home. People facing cancer and their caregivers, when treatment is far from home.
Ronald McDonald House
Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
Healthcare Hospitality Network
Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.

Program details were checked on each program's website on October 24, 2026.

Questions about finding a Mantle Cell Lymphoma trial near you

Are there Mantle Cell Lymphoma clinical trials near me?

As of November 2, 2026, 131 Mantle Cell Lymphoma clinical trials are recruiting or about to open (106 recruiting now, 25 opening soon). In the US, 68 of them have at least 1 open site, across 47 states. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.

Which states have Mantle Cell Lymphoma clinical trial sites?

Recruiting Mantle Cell Lymphoma trials list open sites in 47 states. California, New York and Texas have the most, and the table on this page lists every state.

Are there Mantle Cell Lymphoma trials for children near me?

Of the 68 Mantle Cell Lymphoma trials with a US site, 7 accept children under 18. Their open sites are in 40 states, most often Minnesota, Colorado and New York. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.

Who pays for travel to a Mantle Cell Lymphoma clinical trial?

Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights, and Corporate Angel Network flies cancer patients for free.

What if there is no Mantle Cell Lymphoma trial near me?

Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Mantle Cell Lymphoma trial opens a new site or changes status.

How is the distance to a trial site measured?

Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.

FDA-approved for Mantle Cell Lymphoma: Calquence (acalabrutinib), Brukinsa (zanubrutinib), Jaypirca (pirtobrutinib), Beqalzi (sonrotoclax), Velcade (bortezomib), Revlimid (lenalidomide), Tecartus (brexucabtagene autoleucel), Breyanzi (lisocabtagene maraleucel).

Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 2, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.